Philip Del Vecchio, MD, to director drug regulatory affairs; Edward Betof, PhD, to director of project management.
You may also be interested in...
The US agency has announced another month of webinars aimed at labs and manufacturers that are (or have) developed diagnostic tests for the novel coronavirus.
If bad luck comes in threes, GSK will be delighted to see the end of this week with dostarlimab approval delayed, bintrafusp failing in lung cancer and a Phase II of an ulcerative colitis drug discontinued.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.